CN110546159B - 甲状旁腺激素融合多肽 - Google Patents

甲状旁腺激素融合多肽 Download PDF

Info

Publication number
CN110546159B
CN110546159B CN201880027437.0A CN201880027437A CN110546159B CN 110546159 B CN110546159 B CN 110546159B CN 201880027437 A CN201880027437 A CN 201880027437A CN 110546159 B CN110546159 B CN 110546159B
Authority
CN
China
Prior art keywords
ser
leu
gly
glu
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201880027437.0A
Other languages
English (en)
Chinese (zh)
Other versions
CN110546159A (zh
Inventor
伊恩·威尔金森
理查德·罗斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Sheffield
Original Assignee
University of Sheffield
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Sheffield filed Critical University of Sheffield
Publication of CN110546159A publication Critical patent/CN110546159A/zh
Application granted granted Critical
Publication of CN110546159B publication Critical patent/CN110546159B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201880027437.0A 2017-04-28 2018-04-27 甲状旁腺激素融合多肽 Expired - Fee Related CN110546159B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1706781.0 2017-04-28
GBGB1706781.0A GB201706781D0 (en) 2017-04-28 2017-04-28 Parathyroid hormone fusion polypeptide
PCT/GB2018/051120 WO2018197895A2 (en) 2017-04-28 2018-04-27 Parathyroid hormone fusion polypeptide

Publications (2)

Publication Number Publication Date
CN110546159A CN110546159A (zh) 2019-12-06
CN110546159B true CN110546159B (zh) 2023-08-22

Family

ID=59011076

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880027437.0A Expired - Fee Related CN110546159B (zh) 2017-04-28 2018-04-27 甲状旁腺激素融合多肽

Country Status (7)

Country Link
US (2) US11344606B2 (cg-RX-API-DMAC7.html)
EP (1) EP3609913A2 (cg-RX-API-DMAC7.html)
JP (2) JP2020519250A (cg-RX-API-DMAC7.html)
CN (1) CN110546159B (cg-RX-API-DMAC7.html)
CA (1) CA3061088A1 (cg-RX-API-DMAC7.html)
GB (1) GB201706781D0 (cg-RX-API-DMAC7.html)
WO (1) WO2018197895A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201706781D0 (en) * 2017-04-28 2017-06-14 Univ Sheffield Parathyroid hormone fusion polypeptide
IL284533B2 (en) * 2019-01-11 2024-02-01 Radius Health Inc Methods for detecting antibodies to neutralizing thyroid hormone (PTH) and thyroid hormone-related peptide (PTHRP) analog
CN111876388A (zh) * 2020-07-24 2020-11-03 赛瑞诚(苏州)生物科技有限公司 一种骨和骨组织靶向外泌体及其制备方法和应用
CN118126197B (zh) * 2024-03-19 2025-02-25 康众(广东)生物医药有限公司 一种重组pth融合蛋白及其构建方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
JPH11285388A (ja) 1998-04-03 1999-10-19 Jcr Pharmaceuticals Co Ltd キメラレセプター発現細胞とその用途
WO2001081408A2 (en) 2000-04-21 2001-11-01 New England Medical Center G-protein coupled receptor (gpcr) agonists and antagonists and methods of activating and inhibiting gpcr using the same
MX2007001180A (es) 2004-07-26 2007-04-13 Asterion Ltd Enlazantes.
KR100700869B1 (ko) 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 Pth, 완충제 및 안정제를 포함하는 안정한 pth조성물
ES2583002T3 (es) 2007-04-09 2016-09-16 The Board Of Trustees Of The University Of Arkansas Proteínas de fusión de un dominio de enlazamiento a colágeno y hormona paratiroidea
GB0717985D0 (en) 2007-07-20 2007-10-24 Asterion Ltd Growth hormone fusion proteins
WO2010111617A2 (en) 2009-03-27 2010-09-30 Van Andel Research Institute Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
WO2011101284A1 (en) 2010-02-16 2011-08-25 Novo Nordisk A/S Factor viii fusion protein
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用
GB201104285D0 (en) * 2011-03-15 2011-04-27 Asterion Ltd Modified receptor fusion proteins
US9579273B2 (en) 2011-12-14 2017-02-28 The Kitasato Institute Delivery of therapeutic agents by a collagen binding protein
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
US20150011473A1 (en) 2012-01-20 2015-01-08 Lupin Limited Stabilized pth formulation
CA2919477A1 (en) * 2013-07-31 2015-02-05 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating thermogenesis using pth-related and egf-related molecules
WO2016183297A1 (en) 2015-05-12 2016-11-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Aav isolate and fusion protein comprising nerve growth factor signal peptide and parathyroid hormone
GB201706781D0 (en) * 2017-04-28 2017-06-14 Univ Sheffield Parathyroid hormone fusion polypeptide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
High-level production of recombinant human parathyroid hormone 1-34;YUJI SUZUKI ET AL.;《APPLIED AND ENVIRONMENTAL MICROBIOLOGY》;19980228;第64卷;526-529 *

Also Published As

Publication number Publication date
CN110546159A (zh) 2019-12-06
JP2023027315A (ja) 2023-03-01
EP3609913A2 (en) 2020-02-19
JP2020519250A (ja) 2020-07-02
GB201706781D0 (en) 2017-06-14
US11344606B2 (en) 2022-05-31
US20220218790A1 (en) 2022-07-14
US20200164033A1 (en) 2020-05-28
CA3061088A1 (en) 2018-11-01
WO2018197895A3 (en) 2019-01-17
WO2018197895A2 (en) 2018-11-01

Similar Documents

Publication Publication Date Title
US20220218790A1 (en) Parathyroid hormone fusion polypeptide
EP2858662B1 (en) Fibroblast growth factor 21 proteins
KR100458350B1 (ko) 파라티로이드 호르몬 및 파라티로이드 호르몬 관련펩티드의 유사체를 포함하는 골다공증 치료용 약제학적조성물
CA2246733C (en) Use of a pharmaceutical composition comprising an appetite-suppressing peptide
EP2581389B1 (en) Fusion protein of exendin-4 and its analog, preparation method and use thereof
ES2672770T3 (es) Derivados del péptido-1 similar al glucagón y su uso farmacéutico
WO2019119673A1 (zh) 一种双基因修饰的干细胞及其用途
CN106459222A (zh) Mic‑1融合蛋白及其用途
AU2008278907B2 (en) Growth hormone fusion proteins
AU2013274639A1 (en) Fibroblast growth factor 21 variants
CA2011008C (en) Egf variants and pharmaceutical use thereof
WO2022227707A1 (zh) 一种双靶点融合蛋白的制备方法和应用
JP2018502908A (ja) アルファ‐1‐ アンチトリプシン(a1at)融合タンパク質及びその使用
CN119039417A (zh) 多肽化合物及其应用
ES2316354T3 (es) Derivados polipeptidos de la hormona paratiroidea (pth).
KR20210010365A (ko) 단백질 또는 폴리펩타이드 생산용 융합태그
Ding et al. The effect of albumin fusion structure on the production and bioactivity of the somatostatin-28 fusion protein in Pichia pastoris
JP2025506146A (ja) 哺乳動物細胞におけるヒトアナログインスリン及びその誘導体の製造方法
Miele et al. Expression of Bv8 in Pichia pastoris to identify structural features for receptor binding
RU2471808C2 (ru) Полипептиды модифицированного гормона роста
JPH09157294A (ja) 副甲状腺ホルモン誘導体
CN101274961A (zh) 重组人甲状旁腺素相关蛋白
WO2006018429A1 (en) Multimers of peptides
Ge Presence of inhibin and activin family of hormones and their involvement in the regulation of gonadotropin release in the goldfish, Carassius auratus
WO2007112682A1 (zh) 重组人甲状旁腺激素相关蛋白及其用途

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20230822